Bank Of America Corp Ardelyx, Inc. Put Options Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$5.89 - $9.31 $47,120 - $74,480
-8,000 Reduced 3.57%
216,000 $1.6 Million
Q1 2024

May 15, 2024
SELL
$6.05 - $9.74 $207,515 - $334,082
-34,300 Reduced 13.28%
224,000 $1.64 Million
Q2 2023

Aug 14, 2023
BUY
$3.23 - $4.95 $834,309 - $1.28 Million
258,300 New
258,300 $875,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $864M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email